Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROQUINONE Cause Application site erythema? 9 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Application site erythema have been filed in association with HYDROQUINONE (Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E). This represents 3.3% of all adverse event reports for HYDROQUINONE.

9
Reports of Application site erythema with HYDROQUINONE
3.3%
of all HYDROQUINONE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Application site erythema From HYDROQUINONE?

Of the 9 reports, and 1 (11.1%) were considered life-threatening.

Is Application site erythema Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROQUINONE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROQUINONE Cause?

Squamous cell carcinoma of skin (43) Product use in unapproved indication (38) Drug ineffective (32) Erythema (29) Acne (24) Dry skin (23) Skin atrophy (22) Rash (19) Pruritus (18) Swelling face (18)

What Other Drugs Cause Application site erythema?

NICOTINE (2,004) SUMATRIPTAN (1,875) INGENOL MEBUTATE (1,373) BUPRENORPHINE (1,273) ESTRADIOL (1,117) MINOXIDIL (1,061) METHYLPHENIDATE (543) ESTRADIOL\NORETHINDRONE (533) FENTANYL (501) OXYTROL FOR WOMEN (422)

Which HYDROQUINONE Alternatives Have Lower Application site erythema Risk?

HYDROQUINONE vs HYDROXOCOBALAMIN HYDROQUINONE vs HYDROXYCHLOROQUINE HYDROQUINONE vs HYDROXYCHLOROQUINE DIPHOSPHATE HYDROQUINONE vs HYDROXYETHYL STARCH 130/0.4 HYDROQUINONE vs HYDROXYPROGESTERONE

Related Pages

HYDROQUINONE Full Profile All Application site erythema Reports All Drugs Causing Application site erythema HYDROQUINONE Demographics